Amedeo Smart

Free Medical Literature Service


 

Amedeo

Schizophrenia

  Free Subscription

02.03.2026

1 Acta Psychiatr Scand
1 Can J Psychiatry
2 J Clin Psychopharmacol
1 J Nerv Ment Dis
1 Mol Psychiatry
1 PLoS One
1 Psychiatry Res
1 Psychol Med
3 Schizophr Res



    Acta Psychiatr Scand

  1. BIOQUE M, Perez-Ramos A, Llorca-Bofi V, Penades R, et al
    Clinical Implications of Autistic Features in Patients With a First Episode of Psychosis.
    Acta Psychiatr Scand. 2026 Feb 25. doi: 10.1111/acps.70079.
    >> Share


    Can J Psychiatry

  2. FRANKOW L, Bousman CA, Mathew N, Rafizadeh R, et al
    Clozapine Therapy With or Without Antipsychotic Augmentation: A Retrospective Evaluation of Prescribing Practices in a Canadian Provincial Residential Treatment Centre for Concurrent Disorders: Traitement par la clozapine avec ou sans intensification
    Can J Psychiatry. 2026;71:210-218.
    >> Share


    J Clin Psychopharmacol

  3. MUKAI Y, Kost J, Snow-Adami L, Reed J, et al
    Phase 2b Trial of the PDE10A Inhibitor MK-8189 in People With an Acute Episode of Schizophrenia.
    J Clin Psychopharmacol. 2026 Feb 23. doi: 10.1097/JCP.0000000000002152.
    >> Share

  4. ALABAKU O, Olfson M, Stroup TS, Gerhard T, et al
    The Use of VMAT2 Inhibitors for Tardive Dyskinesia.
    J Clin Psychopharmacol. 2026;46:189-194.
    >> Share


    J Nerv Ment Dis

  5. ABEL DB, Fulford D, Fiszdon JM
    Predicting Social Motivation and Interactions in Schizophrenia: An Ecological Momentary Assessment Study.
    J Nerv Ment Dis. 2026 Feb 27. doi: 10.1097/NMD.0000000000001872.
    >> Share


    Mol Psychiatry

  6. LI X, Zeng J, Liu N, Tang B, et al
    Functional brain abnormalities of cognitive impairments in schizophrenia indicating higher integration of working memory than other domains.
    Mol Psychiatry. 2026 Feb 27. doi: 10.1038/s41380-026-03518.
    >> Share


    PLoS One

  7. STEFANIAK I, Gabor-Siatkowska K, Kozlowski M, Janicki A, et al
    A conversational agent as a virtual therapist for patients diagnosed with schizophrenia: A preliminary study.
    PLoS One. 2026;21:e0343519.
    >> Share


    Psychiatry Res

  8. TESSIER A, Fatseas M, Dansou Y, Godin O, et al
    Tobacco craving and suicidal risk in a cohort of subjects with schizophrenia: results from the national FACE-SZ cohort.
    Psychiatry Res. 2026;359:117028.
    >> Share


    Psychol Med

  9. LILOIA D, Rocca P, Brasso C, Tanaka M, et al
    Identification of a diagnosis-selective neurobiological substrate for bipolar disorder, major depressive disorder, and schizophrenia: a meta-analysis of 57,717 subjects.
    Psychol Med. 2026;56:e52.
    >> Share


    Schizophr Res

  10. KESHAVAN M, Good M
    Response to Gama-Marques et al. commentary: Re-rethinking psychosis.
    Schizophr Res. 2026;291:80.
    >> Share

  11. AHLE G, Henriksen MG, Molstrom IM, Rasmussen AR, et al
    Predictors of violence against others in non-affective psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2026;291:68-79.
    >> Share

  12. LOUREIRO CM, Fachim HA, Bissoli GC, Corsi-Zuelli F, et al
    MC4R methylation and antipsychotic-related metabolic changes in early psychosis: findings from two prospective cohorts.
    Schizophr Res. 2026;291:57-67.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016